FAA closes investigation into Blue Origin rocket failure, requires 21 ‘corrective actions’

FAA closes investigation into Blue Origin rocket failure, requires 21 ‘corrective actions’


The moment of the anomaly during the New Shepard cargo mission NS-23, in which the booster’s engine failed.

Blue Origin

The Federal Aviation Administration closed its investigation into last year’s failed flight of a cargo mission by Jeff Bezos’ Blue Origin, the regulator announced Wednesday.

Blue Origin is required by the FAA to “implement 21 corrective actions,” the regulator said in a statement. The FAA noted that Blue Origin will not be clear to launch New Shepard until after Blue Origin implements “all corrective actions that impact public safety” and receives an updated launch license.

“We’ve received the FAA’s letter and plan to fly soon,” a Blue Origin spokesperson said in a statement.

The 21 required actions include the “redesign of engine and nozzle components to improve structural performance during operation as well as organizational changes.” The FAA did not comment further on specifics of the corrections.

In September 2022, the company’s New Shepard rocket was flying a cargo mission when it suffered a failure. Earlier this year, Blue Origin said the source of the issue was an overheated part in the rocket engine’s nozzle. No people were onboard, as the NS-23 mission was carrying science and research payloads.

Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

Blue Origin said its investigation found that NS-23 flight’s engine failure was due to “operational temperatures that exceeded the expected and analyzed values of the nozzle material.” The company recovered fragments of the BE-3PM engine’s nozzle, finding “clear evidence of thermal damage and hot streaks resulting from increased operating temperatures.”

The New Shepard rocket launches from Blue Origin’s private facility in West Texas, carrying people and payloads above 100 kilometers, or more than 340,000 feet, for a couple minutes of weightlessness. The capsule is flown autonomously, with no human pilot, and floats down with the assistance of a set of parachutes to land in the Texas desert. The New Shepard rocket booster is reusable, returning to land on a concrete pad near the launch site.

To date, Blue Origin has flown 31 people past the edge of space with New Shepard.

Blue Origin has said since March that it expects to return New Shepard to flight “soon.” The crucial re-flight of the rocket is planned to carry the same research payloads that didn’t make it to space on the NS-23 mission, without crew.

Space tourism is a niche market, so why are Virgin Galactic, SpaceX and Blue Origin betting on it?



Source

The cost to fly private is up as much as 20% with fuel prices soaring
Business

The cost to fly private is up as much as 20% with fuel prices soaring

A Gulfstream G-IV private jet on approach to Washington’s Reagan National Airport in Arlington, Virginia, June 12, 2024. J. David Ake | Getty Images As the Iran war pushes jet fuel prices higher, well-heeled travelers are facing hefty surcharges to fly private, sometimes on flights booked months prior, charter brokers and aviation insiders told CNBC. […]

Read More
United unveils basic Polaris business fare in premium cabin overhaul
Business

United unveils basic Polaris business fare in premium cabin overhaul

United Airlines new Polaris seat on one of its Boeing 787 Dreamliners Leslie Josephs/CNBC Does it matter where you sit if you’re sipping Champagne in first class? United Airlines is betting that for some travelers looking for luxury at a discount, it doesn’t. The carrier is launching new, cheaper tiers for its top-end Polaris and […]

Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
Business

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned.  Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]

Read More